Daily non-political popular news in brief.

Space Travel and Cancer Linked? Stony Brook Researcher Secures NASA Grant to Study Effects of Space Radiation

12-12-2007 · Brookhaven National Laboratory

Stony Brook University Medical Center researcher Kanokporn Rithidech has received a $1.4 million grant from NASA to conduct research designed to gain a better understanding about the possible cancer risks encountered by astronauts when they are exposed to space radiation. Research will use BNL's NASA Space Radiation Laboratory.

Keywords: space, travel, cancer, linked, stony, brook, researcher, secures, nasa, grant, study, effects, radiation, secure, effect

« Previous | Next »

Similar news on "Space Travel and Cancer Linked? Stony Brook Researcher Secures NASA Grant to Study Effects of Space Radiation":

Brain stem cells sensitive to space radiation
12-11-2007 · EurekAlert!
Cold Spring Harbor Laboratory scientists recently led a team of researchers to study potential effects of space radiation on astronauts. The results of their study are revealing and will provide the foundation for ensuring the safety of crew members participating in long distance space travel.
Similar news · Read more »
Space radiation threats to astronauts addressed in federal research study
10-25-2006 · EurekAlert!
A better understanding of solar storms and how best to protect astronauts from space radiation is needed as NASA pushes toward manned missions to the moon and Mars in the coming decades, according to a new National Research Council report by a committee chaired by a University of Colorado at Boulder administrator.
Similar news · Read more »
Cetuximab with radiotherapy does not increase side effects for head and neck cancer patients
01-18-2007 · EurekAlert!
The addition of Cetuximab (brand name Erbitux) to radiation therapy treatments does not increase the rate or duration of some side effects in the treatment of advanced head and neck cancers, according to a study presented at the plenary session today at the Multidisciplinary Head and Neck Cancer Symposium, co-sponsored by the American Society for Therapeutic Radiology and Oncology, the American Society for Clinical Oncology and the American Head and Neck Society.
Similar news · Read more »
Secondhand smoke exposure is linked to worsening of lung function for persons with cystic fibrosis
01-29-2008 · EurekAlert!
Exposure to secondhand smoke is associated with adverse effects on lung function among persons with cystic fibrosis, with this effect being worse for persons with certain gene variations, according to a study in the Jan. 30 issue of JAMA.
Similar news · Read more »
Researchers study effects of Aricept in pediatric brain cancer survivors
11-03-2006 · EurekAlert!
A pediatric oncologist at Brenner Children's Hospital is evaluating whether a drug typically used to treat Alzheimer's patients will help brain cancer survivors avoid the learning and memory problems that are common after radiation therapy.
Similar news · Read more »
Anemia treatment may be a double-edged sword
01-30-2008 · EurekAlert!
A study in February's Journal of Clinical Investigation finds that erythropoietin, commonly given for anemia, promotes blood-vessel growth in the eye, an effect that could either improve/worsen disease for patients with cancer, diabetic retinopathy, or retinopathy of prematurity. The effects on retinopathy depend on the timing of when erythropoietin is given.
Similar news · Read more »
Henry Ford Hospital expands research on gene and radiation therapy for prostate cancer
02-06-2008 · EurekAlert!
Henry Ford Hospital is embarking on an expanded major clinical trial involving the use of gene therapy in combination with radiation therapy, to determine if the combined treatment is more effective than radiation therapy alone for patients with intermediate risk prostate cancer.The clinical trial is part of a $9 million grant from the National Cancer Institute awarded to Henry Ford to study the effectiveness of gene therapy to treat prostate cancer.
Similar news · Read more »
Personalized diets may offer relief to advanced cancer patients
03-09-2007 · EurekAlert!
Researchers at the University of Alberta studying the effects of chemotherapy and radiation therapy on the senses report that most advanced cancer patients experience unique and persistent taste and smell abnormalities, believed to be a key factor in malnutrition and poor quality of life. Their study suggests that every patient with chemosensory dysfunction has unique symptoms, and a diet tailored to his/her needs would likely improve quality of life.
Similar news · Read more »
Carbon monoxide counteracts one side-effect of an anti-cancer drug
11-21-2007 · EurekAlert!
Doxorubicin (DOX) is a red-colored anti-cancer drug that carries serious side effects for the heart. These cardio-toxic effects are due to inhibition by DOX of mitochondrial biogenesis, a term used to describe cellular energy generation. In a new study, it is now shown that mitochondrial biogenesis can be recovered in DOX-treated rodents by either inhalation of carbon monoxide or overexpression of the protein HO-1.
Similar news · Read more »
Jefferson scientists studying the effects of high-dose vitamin C on non-Hodgkin lymphoma patients
01-02-2008 · EurekAlert!
Scientists at Thomas Jefferson University Hospital and Jefferson's Kimmel Cancer Center have received approval for a first-of-its kind study on the effect high dose vitamin C has on non-Hodgkin lymphoma patients. Researchers from the Jefferson-Myrna Brind Center of Integrative Medicine and Kimmel Cancer Center in conjunction with the National Institutes of Health will study whether high doses of vitamin C can slow the progression of the deadly disease.
Similar news · Read more »